|
|
Volumn 686, Issue , 2010, Pages 515-525
|
|
Advocacy groups and their role in rare diseases research
|
|
Author keywords
Orphan drug act; Orphan products; Patient advocacy groups; Rare diseases; Social security
|
|
Indexed keywords
ORPHAN DRUG;
ARTICLE;
CLINICAL RESEARCH;
DISEASE REGISTRY;
DRUG INDUSTRY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ACCESS;
HEALTH CARE PERSONNEL;
HEALTH CARE POLICY;
HEALTH ECONOMICS;
HEALTH INSURANCE;
HEALTH PROGRAM;
HUMAN;
MEDICAL RESEARCH;
NATIONAL HEALTH ORGANIZATION;
PATIENT ADVOCACY;
PRIORITY JOURNAL;
RARE DISEASE;
SOCIAL SECURITY;
DRUG MANUFACTURE;
GOVERNMENT;
INTERNATIONAL COOPERATION;
LEGAL ASPECT;
RESEARCH;
REVIEW;
UNITED STATES;
DRUG INDUSTRY;
HUMANS;
INTERNATIONAL AGENCIES;
NATIONAL INSTITUTES OF HEALTH (U.S.);
ORPHAN DRUG PRODUCTION;
PATIENT ADVOCACY;
RARE DISEASES;
RESEARCH;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
UNITED STATES SOCIAL SECURITY ADMINISTRATION;
|
|
EID: 79952060881
PISSN: 00652598
EISSN: None
Source Type: Book Series
DOI: 10.1007/978-90-481-9485-8_28 Document Type: Article |
|
Times cited : (51)
|
|
References (3)
|
